|Articles|July 27, 2015
Janet Freeman-Daily on Why Patients Should Attend the ASCO Meeting
Author(s)Janet Freeman-Daily
Janet Freeman-Daily on why patients should attend the annual meeting of the American Society of Clinical Oncology (ASCO).
Advertisement
We spoke with Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago. Here, Freeman-Daily discusses why patients should attend the meeting.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
New Combination Treatment Approach Studied in Pancreatic Cancer
5